Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 2 from ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy
  1. Home
  2. Publications
  3. Supplementary Figure 2 from ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy

Supplementary Figure 2 from ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy

Authors:
  • BLBotai Li
    Botai Li
  • XWXiaoshuang Wang
    Xiaoshuang Wang
  • BXBowen Xie
    Bowen Xie
  • XZXuan Zhong
    Xuan Zhong
  • PWPeng Wei
    Peng Wei
  • XLXinyi Lou
    Xinyi Lou
  • TZTing Zhang
    Ting Zhang
  • CDChen Dong
    Chen Dong

Open Access
Publisher website
Google Scholar
  • 2 September 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.33414282
Abstract
Supplementary Figure 2. Flow cytometry gating strategies and representative plots.
Keywords
  • GASTROINTESTINAL CANCERS
  • IMMUNOTHERAPY
  • TUMOR MICROENVIRONMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.